glp-1 drugs retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation New Weight Loss Drug -

What weve learned is that GLP-1 acts on widely distributed but metabolically relevant brain circuitry

And for the pharmaceutical giants behind WEGOVY and ZEPBOUND, two of the best-selling drugs in modern history, the oral revolution is both their biggest opportunity and their greatest competitive threat

Acute and prolonged effects of insulin-induced hypoglycemia on the pituitary-thyroid axis in humans

Over the course of a year of treatment with monthly follow-ups, these savings add up meaningfully

Aortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation

Can semaglutide injections damage my throat when I inject